Acidrine in the management of gastritis and duodenitis. A double-blind placebo controlled clinical trial.

Abstract

Thirty-nine adult out-patients with dyspepsia and endoscopically proven gastritis and/or duodenitis without ulcer, completed a double-blind, placebo controlled, 8-week clinical trial of either Acidrine (twenty-one patients) or placebo (eighteen patients), at a daily dosage of 2 tablets t.i.d. Treatment with Acidrine resulted in a significant improvement in symptoms and in the endoscopic appearance of the gastritis and duodenitis when compared with placebo.

• Authors: M Galeone, D Cacioli, G L Toti, G Moise, J Megevand, E Benazzi, F Michetti
• Journal: The Journal of international medical research (J Int Med Res) Vol. 12 Issue 1 Pg. 51-5 ( 1984) ISSN: 0300-0605 [Print] England
• PMID: 6363157 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Bridged-Ring Compounds
• Drug Combinations
• Organometallic Compounds
• Polysaccharides
• aluminium glycinate, myrtecaine drug combination
• Aluminum

Topics

• Adult
• Aluminum (therapeutic use)
• Bridged-Ring Compounds (therapeutic use)
• Clinical Trials as Topic
• Double-Blind Method
• Drug Combinations (therapeutic use)
• Duodenitis (drug therapy)
• Female
• Gastritis (drug therapy)
• Gastroscopy
• Humans
• Male
• Organometallic Compounds
• Polysaccharides (therapeutic use)
• Random Allocation